Do you have a robust strategy?
The why
The challenge
Our client wanted to pressure-test their strategy to ensure their choices would remain robust in a rapidly changing market. Although their existing business model was currently a strong cash cow, they recognised it could be challenged in the future. They therefore sought a framework to help navigate strategic decisions within a range of plausible future contexts.
How we helped
Applying our scenario-planning methodology to the focal question involved analysing future drivers through expert interviews, AI-supported insights, and data within a PESTLE (Political, Economic, Social, Technological, Legal, and Environmental) framework. By zooming in on the drivers where no consensus existed, we identified the most critical uncertainties — forming the basis for a set of plausible future scenarios. Through detailed scenario narratives, these futures came to life and shaped strategic discussions around the client’s most robust strategic choices.
Outcome
Scenario Planning is a powerful tool for executives and boards to pressure-test their strategies.Scenario Planning is a practical tool for regular board discussions on navigating complexity
What moved the needle
Jonas T. Karlsen, Ph.D.
Jonas is a life science strategist supporting executives drive progress across the value chain. He is an expert in bridging strategy and execution via global operating model design and transformation rooted in strategic objectives. He engages with structured top-down thinking and a pragmatic and collaborative approach to mobilise organizations and make things happen.
Jonas holds a Ph.D. in biophysics from the Technical University of Denmark, DTU, and further studied at California Institute of Technology. Recipient of the Ministry of Sciences Elite Research Award.
Selected experience
- Ecosystem integration and external innovation pipeline
- Lab of the future capability building and operating model design
- Global clinical operating model design and transformation
- Pre-launch strategy for cardiometabolic TA development